| 1/3 | US=14 / Dermatologia Perrett CM, Harwood CA, McGregor JM, Karran P. Carcinogenic mechanisms related to immunosuppressive therapy. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 123-32. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8. MECANISMOS CANCERIGENOS; TERAPIA IMUNOSSUPRESSORA; CARCINOGENESE; GLUCOCORTICOIDES; CICLOSPORINA; AZATIOPRINA; INIBIDORES DE MTOR |
| 2/3 | US=14 / Dermatologia Morelon E, Mahe E, Touraine JL. The role of the transplant physician in the management of skin cancers after organ transplantation. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 377-90. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8. CANCER DE PELE; RESPONSABILIDADE MEDICA; TRANSPLANTE DE ORGAOS; CLINICO DE TRANSPLANTE; IMUNOSSUPRESSAO; INIBIDORES DE MTOR; CANCER DE PELE NAO MELANOMA |
| 3/3 | US=77-J / Câncer Formiga MNC. Terapias alvos específicos. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 235-7. ISBN 8-5866523-7-0. CANCER. TERAPIA; INIBIDORES DE ANGIOGENESE; INIBIDORES DE MTOR; INIBIDORES DE EGFR; AGENTES ANTI-SENSE; RNA DE INTERFERENCIA (RNAI) |